Norris Medicines

Norris_Medicines26 Apr 2024

Pharmaceuticals

₹

-0.25 (-1.93%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Norris Medicines

Norris Medicines

Pharmaceuticals

Norris_Medicines26 Apr 2024

₹

-0.25 (-1.93%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-Mar-2024	BC	Outcome of Board Meeting held on 29-04-2024	29-Mar-2024
29-Mar-2024	BC	Outcome of Board Meeting held on 29-04-2024	28-Mar-2024
22-Mar-2024	BC	Outcome of Independent Directors Meeting	22-Mar-2024
08-Feb-2024	BC	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and take on record the Un-	14-Feb-2024
29-Dec-2023	BC	Outcome of Board Meeting held on 29-12-2023 Covering letter and Notice of Extra Ordinary General Meeting to be held on 30-01-2024 (As Per BSE Announcement dated on 08.01.2024) Outcome of Ext	30-Jan-2024

No Rights has been declared by Norris_Medicines

Book Closure

Record Date	Split Date	Purpose
29-Mar-2024	-	Outcome of Board Meeting held on 29-04-2024
28-Mar-2024	-	Outcome of Board Meeting held on 29-04-2024
22-Mar-2024	-	Outcome of Independent Directors Meeting
14-Feb-2024	-	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and take on record the Un-
30-Jan-2024	-	Outcome of Board Meeting held on 29-12-2023 Covering letter and Notice of Extra Ordinary General Meeting to be held on 30-01-2024 (As Per BSE Announcement dated on 08.01.2024) Outcome of Ext

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Norris Medicines Ltd ₹12.67(-0.25/-1.93%)	12.67	-0.25	12.67	0.00	0.00	-0.94
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.65	2.56	0.95	1.21	3.16	3.03
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.65	2.56	0.95	1.21	3.16	3.03
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.01	0.00	0.00
Total Income	0.65	2.56	0.95	1.23	3.17	3.03
Total Expenditure	0.69	2.80	1.33	0.67	2.83	2.79
PBIDT	-0.04	-0.25	-0.39	0.56	0.34	0.24
Interest	0.09	0.09	0.09	0.37	0.39	0.65
PBDT	-0.13	-0.33	-0.47	0.19	-0.05	-0.41
Depreciation	0.14	0.14	0.14	0.18	0.15	0.15
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.56	0.00	0.00
Reported Profit After Tax	-0.27	-0.48	-0.61	-0.54	-0.20	-0.56
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.27	-0.48	-0.61	-0.54	-0.20	-0.56

EPS (Unit Curr.)	-0.27	-0.48	-0.61	-0.54	-0.20	-0.56
EPS (Adj) (Unit Curr.)	-0.27	-0.48	-0.61	-0.54	-0.20	-0.56
Calculated EPS (Unit Curr.)	-0.27	-0.48	-0.62	-0.55	-0.20	-0.57
Calculated EPS (Adj) (Unit Curr.)	-0.27	-0.48	-0.62	-0.55	-0.20	-0.57
Calculated EPS (Ann.) (Unit Curr.)	-1.09	-1.92	-2.48	-2.19	-0.82	-2.27
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-1.09	-1.92	-2.48	-2.19	-0.82	-2.27
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	9.93	9.93	9.93	9.93	9.93	9.93
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-6.15	-9.77	-41.05	46.28	10.76	7.92
PBDTM(%)	-20.00	-12.89	-49.47	15.70	-1.58	-13.53
PATM(%)	-41.54	-18.75	-64.21	-44.63	-6.33	-18.48

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	9.93	9.93	9.93	9.93	9.93	9.93
Reserves Total	-22.37	-20.62	-17.36	-12.39	-9.55	-7.88
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-12.44	-10.69	-7.43	-2.46	0.38	2.05
Secured Loans	3.24	3.42	0.57	2.94	0.00	0.02
Unsecured Loans	18.16	17.66	14.95	14.98	11.24	7.69
Total Debt	21.40	21.08	15.52	17.92	11.24	7.71
Total Liabilities	8.96	10.39	8.09	15.46	11.62	9.76
APPLICATION OF FUNDS :
Gross Block	27.95	27.92	27.87	27.78	27.70	27.41
Less : Accumulated Depreciation	21.48	20.85	20.20	19.53	18.80	18.09
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	6.47	7.07	7.67	8.25	8.90	9.32
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.01	0.01
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.20	2.42	5.10	4.01	3.76	4.47
Sundry Debtors	1.10	1.09	1.79	2.76	3.01	2.47
Cash and Bank	0.02	0.02	0.02	0.06	0.08	0.10
Loans and Advances	0.60	0.74	1.32	0.61	0.54	0.59
Total Current Assets	4.92	4.27	8.23	7.44	7.40	7.63
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.93	1.64	10.54	3.49	7.45	9.94
Provisions	2.79	2.17	1.15	1.62	1.32	0.98
Total Current Liabilities	4.72	3.81	11.69	5.11	8.77	10.92
Net Current Assets	0.20	0.46	-3.46	2.33	-1.37	-3.29
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.61	2.69	3.66	3.66	2.82	2.48
Deferred Tax Liability	0.56	1.08	0.97	0.00	0.00	0.00
Net Deferred Tax	1.05	1.61	2.69	3.66	2.82	2.48
Total Assets	7.73	9.15	6.91	14.25	10.36	8.52
Contingent Liabilities	1.33	1.33	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.02	0.02	0.06	0.08	0.10
Net Cash from Operating Activities	1.20	-1.01	1.11	-2.88	-1.92
Net Cash Used In Investing Activities	-0.02	-0.09	-0.06	0.00	-0.29
Net Cash Used In Financing Activities	-1.18	1.10	-1.09	2.86	2.18
Net Inc./Dec In Cash And Cash Equivalents	0.00	0.00	-0.04	-0.02	-0.02
Cash And Cash Equivalents At End Of The Year	0.02	0.02	0.02	0.06	0.08

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

34.01%

FII Shareholding

0.00%

DII Shareholding

0.07%

Public Shareholding

65.92%

**Promoter pledged shareholding 34.01%

About Norris Medicines Ltd

Norris Medicines Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 12.67 crores. It has reported a sales of Rs. 0.65 crores and a net profit of Rs. -0.27 crores for the quarter ended December 2018. The company management includes , Vimal D Shah,Hiten Parikh,S A M Azmathullah,Susmita Mahapatra,Prerna Karwa (Norris Medicines Ltd) among others.

Chairman

Registered office

Plot No 801/P & 802,GIDC Industrial Estate,Ankleshwar,Gujarat,393002

FAX :91-2646-250126

Background

Incorporation Year1990

Face Value₹10

Market Lot1

How to buy Norris Medicines shares on nse?

To buy Norris Medicines shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Norris Medicines share price today?

The Norris Medicines shares price on nse is Rs.12.67 today.

What is the market cap of Norris Medicines shares on BSE ?

The company has a market capitalization of Rs.12.67Cr

What is the PE & PB ratio of Norris Medicines shares ?

PE is 0 and PB is -0.94

What is the 52 Week High and Low of Norris Medicines shares?

Norris Medicines stock price high: Rs.27.51 Norris Medicines stock price low: Rs.10.05